CGC
Price
$1.21
Change
-$0.00 (-0.00%)
Updated
Jun 3 closing price
Capitalization
784.64M
76 days until earnings call
NBIX
Price
$125.00
Change
+$0.44 (+0.35%)
Updated
Jun 3 closing price
Capitalization
13.72B
62 days until earnings call
Interact to see
Advertisement

CGC vs NBIX

Header iconCGC vs NBIX Comparison
Open Charts CGC vs NBIXBanner chart's image
Canopy Growth
Price$1.21
Change-$0.00 (-0.00%)
Volume$6.28M
Capitalization784.64M
Neurocrine Biosciences
Price$125.00
Change+$0.44 (+0.35%)
Volume$1.31M
Capitalization13.72B
CGC vs NBIX Comparison Chart
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. NBIX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and NBIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (CGC: $1.21 vs. NBIX: $125.00)
Brand notoriety: CGC: Notable vs. NBIX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 80% vs. NBIX: 77%
Market capitalization -- CGC: $784.64M vs. NBIX: $13.72B
CGC [@Pharmaceuticals: Other] is valued at $784.64M. NBIX’s [@Pharmaceuticals: Other] market capitalization is $13.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileNBIX’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • NBIX’s FA Score: 0 green, 5 red.
According to our system of comparison, NBIX is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while NBIX’s TA Score has 5 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 6 bearish.
  • NBIX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NBIX is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а -28.82% price change this week, while NBIX (@Pharmaceuticals: Other) price change was +1.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +13.58%. For the same industry, the average monthly price growth was +15.20%, and the average quarterly price growth was +63.51%.

Reported Earning Dates

CGC is expected to report earnings on Aug 19, 2025.

NBIX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+13.58% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than CGC($785M). NBIX YTD gains are higher at: -8.425 vs. CGC (-55.839). NBIX has higher annual earnings (EBITDA): 358M vs. CGC (-1.02B). NBIX has more cash in the bank: 1.03B vs. CGC (186M). NBIX has less debt than CGC: NBIX (428M) vs CGC (693M). NBIX has higher revenues than CGC: NBIX (1.89B) vs CGC (362M).
CGCNBIXCGC / NBIX
Capitalization785M13.7B6%
EBITDA-1.02B358M-286%
Gain YTD-55.839-8.425663%
P/E RatioN/A57.20-
Revenue362M1.89B19%
Total Cash186M1.03B18%
Total Debt693M428M162%
FUNDAMENTALS RATINGS
CGC vs NBIX: Fundamental Ratings
CGC
NBIX
OUTLOOK RATING
1..100
722
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10071
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8949
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBIX's Valuation (72) in the Biotechnology industry is in the same range as CGC (91) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's SMR Rating (100) in the Biotechnology industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's Price Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for CGC (89) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew somewhat faster than CGC’s over the last 12 months.

NBIX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCNBIX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 6 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 13 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYTIX209.61N/A
N/A
Rydex Technology Inv
FLCOX18.61N/A
N/A
Fidelity Large Cap Value Index
NWXUX10.78N/A
N/A
Nationwide International Sm Cp R6
GWGZX17.56N/A
N/A
AMG GW&K Small Mid Cap Core Z
BBTIX12.69-0.09
-0.70%
Bridge Builder Tax Managed Intl Eq